Salles C A, Moreira M C, Borem P M, Gusmăo J B, Teixeira V C, Silva R R, Prates H F, Araujo E S, Gelape C L, Silva S R
Hospital Felicio Rocho, Belo Horizonte, M.G., Brazil.
J Heart Valve Dis. 1998 May;7(3):305-12.
A bovine pericardial conduit processed in glutaraldehyde was designed, incorporating the principle of crimping used for synthetic vascular prostheses. The crimping process did not affect the integrity of collagen fibers and tissue structure. This conduit, designed for aortic reconstruction, is available in different sizes, with or without a biological valve.
Between October 1989 and May 1997, 40 patients with aortic dissection, aortic aneurysm, aortic coarctation or aortoiliac occlusive disease underwent aortic reconstruction using this vascular substitute. Procedures included total reconstruction of the ascending aorta and aortic valve with reimplantation of coronary arteries (nine patients), single ascending thoracic aorta (six), descending thoracic aorta (two), aortic arch (one) and thoracoabdominal aorta (one); the abdominal aorta was reconstructed in 21 cases, including those undergoing aortoiliac or aortofemoral bypass.
The hospital mortality rate was 20% (eight patients); causes of deaths were low cardiac output, recurrence of aortic dissection, multiple organ failure and bleeding. Mean follow up was 3.6 years; total follow up was 114 patient-years. Late conduit-related complications occurred in four patients, including a limb obstruction in one patient subjected to aortofemoral bypass and infection of three resulting in pseudoaneurysm (incidence of 3.5 +/- 1.8% per patient-year). All underwent reoperation. There were four late deaths due to sudden death, coronary artery disease, pneumonia and metabolic complications of diabetes and renal failure (incidence of 3.5 +/- 1.8% per patient year). The eight-year actuarial survival rate was 63.7 +/- 11.6%, including hospital mortality, and the eight-year actuarial freedom from conduit failure due to primary tissue structural degeneration was 100%.
The crimping design provides a circular tube which makes construction of the anastomosis easier, retains its shape with bending, and avoids kinking. The material is very soft, easy to handle and suture, coapts nicely to suture lines resulting in a hemostatic anastomosis. The eight-year follow up demonstrated a satisfactory performance without report of fibrosis, calcification or aneurysmal dilation.
设计了一种经戊二醛处理的牛心包导管,采用了用于合成血管假体的压接原理。压接过程未影响胶原纤维的完整性和组织结构。这种为主动脉重建设计的导管有不同尺寸,带或不带生物瓣膜。
1989年10月至1997年5月期间,40例患有主动脉夹层、主动脉瘤、主动脉缩窄或主-髂动脉闭塞性疾病的患者使用这种血管替代物进行了主动脉重建。手术包括升主动脉和主动脉瓣的全重建并冠状动脉再植入(9例患者)、单纯升胸主动脉重建(6例)、降胸主动脉重建(2例)、主动脉弓重建(1例)和胸腹主动脉重建(1例);21例患者进行了腹主动脉重建,包括那些接受主-髂动脉或主-股动脉旁路手术的患者。
医院死亡率为20%(8例患者);死亡原因是低心输出量、主动脉夹层复发、多器官功能衰竭和出血。平均随访3.6年;总随访时间为114患者年。4例患者出现晚期导管相关并发症,包括1例接受主-股动脉旁路手术的患者出现肢体阻塞,3例感染导致假性动脉瘤(发生率为每年3.5±1.8%/患者)。所有患者均接受了再次手术。有4例晚期死亡,原因分别为猝死、冠状动脉疾病、肺炎以及糖尿病和肾衰竭的代谢并发症(发生率为每年3.5±1.8%/患者)。包括医院死亡率在内的八年精算生存率为63.7±11.6%,因原发性组织结构退变导致导管失败的八年精算无发生率为100%。
压接设计提供了一个圆形管,使吻合口的构建更容易,弯曲时能保持其形状,避免扭结。该材料非常柔软,易于操作和缝合,能很好地贴合缝合线,实现止血吻合。八年随访显示其性能令人满意,未报告纤维化、钙化或动脉瘤样扩张。